North Coast Technology Investors

Betterworks is the pioneer in intelligent performance management software solutions. Its flexible, enterprise-ready SaaS platform helps workforces and organizations achieve their highest potential with tools that foster greater manager effectiveness and employee performance, leading to higher engagement and retention and, ultimately, better business outcomes. The Betterworks solution combines generative AI and data analytics that enable organizations to make smart, data-informed decisions linked to performance, calibration, skill development, career development, and succession planning. As a comprehensive, purpose-built performance management solution, it incorporates goal-setting, manager-employee conversations, feedback, employee engagement, and recognition — all accessible in the applications employees use daily in the flow of work, like email, calendars, and messaging apps. Betterworks’ modules capture structured and unstructured data to provide HR with both comprehensive and granular views of employee performance. This enables managers to easily coach employees in both performance and career development, continuously improving performance and elevating the employee experience.

BlueWillow Biologics operates as a clinical-stage, privately-held biopharmaceutical company. It focuses on developing and commercializing topical antiseptic and anti-infective products and intranasal vaccines using its patented nanotechnology platform. Its platform employs novel oil-in-water nano-droplets for products administered to the skin and nose. The company was founded as a spin-off from the University of Michigan and is headquartered in Ann Arbor, Michigan.

Impact Analytical is a contract testing laboratory supporting all phases of drug development and manufacturing, consumer products, medical device testing, plastics, specialty chemicals, packaging and automotive. They offer method development, validation, stability, extractables & leachables, problem solving, unknown identification, release testing, competitive analysis, failure analysis, raw material testing, surfactant analysis, and many other services. They have 30+ years of polymer and chemistry analysis experience. Impact Analytical is a GMP registered, GLP compliant (FDA, EPA), ISO 9001 certified, and DEA licensed. They are routinely audited by the FDA with no findings (483’s). Their customer-focused approach differentiates us in the industry and ensures you receive high quality results that are on-time and on-budget. Please contact us to schedule a facility audit and discuss your next project.

Delphinus Medical Technologies develops, commercializes, sells, and services breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy.

VNN is the largest and fastest growing high school sports marketing platform in America. As the exclusive web/mobile platform for over 7million passionate fans across 40+ states (adding 8,000 fans daily), VNN is rapidly aggregating the fragmented, multi-billion dollar high school sports market onto an intelligent platform that transforms the consumer experience of high school sports.

Larky is a mobile and web platform that helps organizations connect with their audiences at the right time and place. Clients include banks, credit unions, health insurance providers, employers, universities and more. Larky serves clients in 20 US states and Canada.

VNN is the largest and fastest growing high school sports marketing platform in America. As the exclusive web/mobile platform for over 7million passionate fans across 40+ states (adding 8,000 fans daily), VNN is rapidly aggregating the fragmented, multi-billion dollar high school sports market onto an intelligent platform that transforms the consumer experience of high school sports.

Delphinus Medical Technologies develops, commercializes, sells, and services breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy.

We’re on a mission. At Waymark, we believe great video should be accessible to everyone and we’re building the tools to make that a reality. Whether you're a brand, enterprise, media platform, agency, or even a small business, Waymark’s anyone-can-edit video technology makes it easy to scale video and accelerate your business. With Waymark, anyone can make beautiful videos effortlessly. No creativity required. We’re a team of tenacious people who don’t take no for an answer and live at the intersection of design and technology. We launched Waymark in 2017 and have been building it with care ever since.

Larky is a mobile and web platform that helps organizations connect with their audiences at the right time and place. Clients include banks, credit unions, health insurance providers, employers, universities and more. Larky serves clients in 20 US states and Canada.

Myine Electronics, LLC, doing business as Livio Radio, designs and manufactures electronic audio products. Its products include Bluetooth Internet radio car kits for iPhones and Android phones, and car audio players. The company also provides Livio Connect API, a middleware framework protocol that enables hardware to connect to and interact with various mobile phone applications. It offers its products through retailers, resellers, and online. Myine Electronics, LLC was formerly known as Myine Corporation. The company was founded in 2008 and is based in Ferndale, Michigan.

CytoPherx (formerly Nephrion) clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.

Delphinus Medical Technologies develops, commercializes, sells, and services breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy.

CytoPherx (formerly Nephrion) clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.

RenaMed Biologics a biotechnology company, engages in the development and commercialization of therapies for the treatment of diseases associated with compromised kidney function. The company focuses on patients suffering from acute renal failure and additional indications where kidney function is compromised. It develops RBI-01, which utilizes physiologically active human renal epithelial cells and administered ex vivo, to replace and maintain severely compromised, or lost kidney functions due to illness, or trauma. The company was founded in 1995 as Nephros Therapeutics, Inc. and changed its name to RenaMed Biologics, Inc. in 2005. RenaMed Biologics, Inc. is based in Lincoln, Rhode Island.

Arbortext offers a XML-based software solution that enables its users to create, edit, and publish contents on multichannel platforms. Arbortext is acquired by Parametric Technology. Arbortext was founded in December 1982 and is based in Ann Arbor, Michigan.

NTT Global Networks provides telecommunications services. They offer a cloud framework to automatically activate and configure virtualized IT cloud services for branch offices.

ONE is an industry leader in convergence management technology—offering comprehensive, web-based solutions for network management. With a thorough understanding of industry needs, their solutions offer ONE access point to a world of converging technology. ONE believes that to effectively manage the convergence of the services and technologies defining the networks of today and tomorrow, management systems and management applications must also converge. Their vision is the creation of a convergence management layer in the network where applications that manage services and equipment can work together seamlessly and can evolve and scale as does the network. Their mission is to make convergence management a reality for their clients.